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Expression and Subcellular Localization of TRPC3, Orai1, and STIM1
after Pressure Overload-Induced Hypertrophy in Adult Cardiac Myocytes
Senka Ljubojevic, Simon Sedej, Michael Holzer, Gunther Marsche,
Vanja Marijanski, Jens Kockska¨mper, Burkert Pieske.
Recent studies have suggested that store-operated Ca2þ entry (SOCE) regulates
physiological and pathological cardiac growth. Molecular players identified to
contribute to SOCE are TRPC family members and the ORAI1/STIM1 complex
found in neonatal cardiomyocytes (CMs). However, whether the expression and
subcellular distribution of TRPC3,ORAI1 and STIM1 are changed in adult CMs
during the development and progression of hypertrophy, remains unknown.
Pressure overload-induced hypertrophy was induced by minimally invasive
transverse aortic constriction (TAC) in adult wild-type mice. Sham-operated
mice served as controls. Left ventricular tissue homogenates obtained 1, 3,
and 6 weeks after TAC were subjected to immunoblotting. Immunocytochem-
istry was performed in isolated CMs 6 weeks after TAC.
TRPC3, ORAI1, and STIM1 were constitutively expressed in Sham and TAC
hearts. Co-immunoprecipitation revealed association of STIM1 with ORAI1
and TRPC3. Following TAC, mice developed progressive hypertrophy as evi-
denced by echocardiographic parameters and gravimetric analysis. In TAC
hearts, TRPC3 expression progressively increased (1week:þ1350%; 3weeks:
þ3251%; 6weeks:þ3351%), whereas ORAI1 expression decreased (1week:
3251%; 3weeks: 3852%; 6weeks: 3852%) during the progression of
hypertrophy. STIM1 expression remained unchanged (n=7). In Sham CMs,
TRPC3 was distributed in a striated pattern throughout the cells. ORAI1 was
expressed on the plasma membrane and in a striated pattern throughout the
cells, with the higher density in the cell periphery. STIM1 appeared in a punc-
tate pattern throughout the cells. In TAC CMs, by contrast, TRPC3 was pre-
dominantly found in the cell periphery. ORAI1 and STIM1 subcellular
distribution appeared unaffected during pressure overload.
In summary, we observed altered expression of TRPC3 and ORAI1 and altered
subcellular distribution of TRPC3 in pressure overload-induced hypertrophy in
mice. The results raise the possibility that altered SOCE may contribute to the
development and/or progression of hypertrophy.
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Calcineurin a Subunit Silencing Reduces Serca2 Expression in Cardiac
Myocytes
Anand M. Prasad, Giuseppe Inesi.
Resting intracellular Ca2þ can be raised, in neonatal rat cardiac myocytes, by
exposure to very low concentration of thapsigargin (TG). Such a Ca2þ rise
yields calcineurin (CN) activation, demonstrated by increased expression of
transfected luciferase cDNA under control of nuclear factor of activated T-cells
(NFAT) promoter. We found that exposure of cardiac myocytes to TG is fol-
lowed by increase of SERCA2 expression, which is further increased when
CN inactivation by CAMKII (calmodulin dependent kinase) is prevented
with KN93 (CAMKII inhibitor). On the other hand, SERCA2 expression is re-
duced by CN inhibition with cyclosporine. We have now induced calcineurin A
(CNA) alpha or beta subunit gene silencing with siRNA, and observed strong
interference with expression of SERCA2, both in control myocytes and follow-
ing exposure to TG. Such interference is also obtained following NFAT dis-
placement from calcineruin with INCA-6. We have also observed analogous
effects on expression of phospholamban (PLB) and Naþ/Ca2þ exchanger
(NCX). Pertinent to these findings, we have identified, by in-silico analysis,
NFAT binding sites in SERCA2, PLB and NCX promoters. Our experiments
indicate that activation of the calcineurin/NFAT pathway by rise of resting cy-
tosolic Ca2þ elevates transcription/expression of SERCA2, PLB and NCX, pro-
viding a homeostatic mechanism for long term control of cytosolic Ca2þ
(Supported by 5 R01 HL069830-08).
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Changes in Ca2þ/Calmodulin-Dependent Protein Kinase (CaMKII) Dur-
ing Development of Hypertension-Induced Hypertrophy and Heart Fail-
ure
David Yu, Julie Bossuyt, Jeffery Erickson, Byron Norton,
Marius P. Sumandea, Leighton T. Izu, Donald M. Bers, Ye Chen-Izu.
CaMKII is important in cardiac function and disease, and the two main cardiac
isoforms (dC and dB) are targeted to cytosol and nucleus respectively. They
regulate many ion channels and Ca2þ handling molecules in excitation-contrac-
tion coupling and also participate in transcriptional control and hypertrophic/
heart failure signaling. Here we investigate changes in dB and dC expression
and activity during the development of Hypertensive Heart Diseases (HHD)
through four progressive stages: (1) pre-hypertension, (2) onset of hypertensionprior to hypertrophy, (3) overt hypertrophy, and (4) heart failure. Method:
Western blots were used to measure the dB and dC expression and phosphor-
ylation at Thr286/Thr305 (indicating enzyme activity) in the left ventricle of
spontaneously hypertensive rat (SHR) at distinct stages of HHD vs. age-
matched normotensive Wistar-Kyoto rat (WKY). MAJOR RESULTS: (1) dB
and dC expression and phosphorylation in WKY gradually increased with
age. (2) SHR show different dB and dC expression and phosphorylation
from WKY, revealing disease-related changes apart from age-related changes.
(3) Both dB and dC activity increased at the onset of hypertension, and per-
sisted during hypertrophy and heart failure. (4) Interestingly, dB shows larger
changes at earlier stages of hypertension and hypertrophy than dC, while dC
shows larger changes at heart failure, implicating differential roles of each in
regulating hypertrophy and transition to heart failure. (5) ACE inhibitor treat-
ment of SHR at each disease stage effectively reduced hypertension and also
reversed changes in dB and dC. CONCLUSION: CaMKII dB and dC are im-
mediate responders to the onset of hypertension and mediate the development
of hypertrophy and heart failure during chronic hypertension.
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Calcium Signaling inMouse VentricularMyocytes with Impaired Calmod-
ulin Regulation of Ryr2
Juan Jose´ Arna´iz-Cot, Susannah L. Stone, Gerhard Meissner,
Naohiro Yamaguchi, Martin Morad.
The cardiac muscle ryanodine receptor ion cannel (RyR2) is a 560 kDa homo-
tetramer that is regulated by calmodulin (CaM), which decreases the open prob-
ability of RyR2 at diastolic and systolic Ca2þ concentrations. Point mutations
in the CaM binding domain of RyR2 (W3587A/L3591D/F3603A, RyR2ADA)
result in severe cardiac hypertrophy, reduced RyR2 concentration, and death
by postnatal day 16, which suggests that CaM inhibition of RyR2 is required
for normal cardiac function. Little is known, however, about Ca2þ signaling
of the mutant mouse hearts. Here, we report on Ca2þ signaling of enzymatically
isolated cardiac myocytes of 11-15 day old wild type and homozygous
RyR2ADA/ADA mouse hearts. Cardiomyocytes, dialyzed with the fluorescence
probe Fluo-4, were voltage-clamped and subjected to 2-dimensional rapid con-
focal imaging. At holding potentials of80 mV, the Ca2þ spark frequency was
7-fold lower in mutant (0.6150.40 sparks/sec, n=7) compared to wild type
(4.0451.07/sec, n=7) myocytes. Further, preliminary data indicate that the am-
plitude of the Ca2þ transients, triggered by membrane depolarization, was
lower in voltage-clamped mutant cells than in wild type cells, even though caf-
feine-triggered Ca2þ release was larger in mutant cardiomyocytes. The data
suggest that RyR2ADA mutation reduces resting Ca2þ spark frequency and de-
polarization-induced SR Ca2þ release in presence of increased SR Ca2þ store
size. The reduction of RyR2 expression in RyR2ADA/ADA hearts may, in part,
contribute to this phenotype.
Supported by NIH (HL16152 and HL073051), NSF (EPS-09037395) and AHA
(10SDG3500001).
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Molecular Mechanism of Alpha-CaMKII Self-Association
Nicole M. Ashpole, Derrick E. Johnson, Andy Hudmon.
Calcium/calmodulin-dependent protein kinase II, CaMKII, is a calcium-depen-
dent serine/threonine kinase associated with ischemia and other neurodegener-
ative diseases. Biochemical studies have shown that CaMKII undergoes an
activity-dependent aggregation, termed self-association, when activated in an
ischemic-like environment - reduced pH, reduced ATP availability. To date,
the molecular mechanisms differentiating CaMKII self-association from target-
ing are not known, as mutants such as Thr286Ala which disrupt self-association
also disrupt targeting. Interestingly, self-association is only seen with aCaMKII
and not bCaMKII. While these isoforms are highly conserved, sequence align-
ment of the catalytic and autoregulatory domains highlight several amino acids
that vary between aCaMKII and bCaMKII, including residues which may
serve as pH sensors (bH38, aH84, aH273) or potential crosslink sites (bC35,
bC148, bC272). Thus, we constructed aCaMKII/bCaMKII chimeras to iden-
tify mutations in aCaMKII that would prevent self-association. Unlike wild-
type aCaMKII, GFP-a/bCaMKII chimeras failed to self-associate in
HEK293 cells subjected to ionomycin/calcium at pH 6.5 - a cell-based model
where self-association is monitored in real-time using fluorescent microscopy.
Recombinant aCaMKII, bCaMKII, and a/bCaMKII chimeras were expressed,
purified, and their enzymatic properties and ability to self-associate were mea-
sured in controlled conditions in vitro. No differences were observed for any of
the wild-type or mutant enzymes to bind or phosphorylate substrates, suggest-
ing that the a/bCaMKII chimeras are enzymatically identical to wild-type pro-
teins. Using Rayleigh light-scattering to monitor aCaMKII self-association in
vitro, the a/bCaMKII chimera, like bCaMKII, did not undergo self-association.
These data suggest that key residues in the catalytic and autoregulatory domain
